The Art of Timing: Recognizing Signs and Symptoms of Advanced Heart Failure to Guide Timely Referral to Advanced Heart Failure Specialists

References

[1] Lam CSP, Yancy C. Universal definition and classification of heart failure: is it universal? Does it define heart failure? J Card Fail. 2021. Vol. 27(5):509-11

[2] Writing Committee Members. HF STATS 2025: Heart failure epidemiology and outcomes statistics an updated 2025 report from the Heart Failure Society of America. J Card Fail. 2026. Vol. 32(2):439-98

[3] Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al.. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022. Vol. 79(17):e263-421.

[4] Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Brouse S, Butler J, et al.. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024. Vol. 83(15):1444-88

[5] Mohebi R, Wang D, Lau ES, Parekh JK, Allen N, Psaty BM, et al.. Effect of 2022 ACC/AHA/HFSA criteria on stages of heart failure in a pooled community cohort. J Am Coll Cardiol. 2023. Vol. 81(23):2231-42.

[6] Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, et al..ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm. 2013. Vol. 10(4):e11-58

[7] Costanzo MR, Augustine S, Bourge R, Bristow M, O’Connell JB, Driscoll D, et al.. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995. Vol. 92(12):3593-612

[8] Baumwol J. “I Need Help”-A mnemonic to aid timely referral in advanced heart failure. J Heart Lung Transplant. 2017. Vol. 36(5):593-4

[9] Sami F, Acharya P, Noonan G, Maurides S, Al-Masry AA, Bajwa S, et al.. Palliative inotropes in advanced heart failure: comparing outcomes between milrinone and dobutamine. J Card Fail. 2022. Vol. 28(12):1683-91

[10] Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, et al.. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation. 2017. Vol. 135(22):e1054-91.

[11] Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, et al.. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017. Vol. 19(7):821-36

[12] Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, et al.. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005. Vol. 112(24):3738-44

[13] MacIntyre CJ, Sapp JL, Abdelwahab A, Al-Harbi M, Doucette S, Gray C, et al.. The effect of shock burden on heart failure and mortality. CJC Open. 2019. Vol. 1(4):161-7

[14] Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ. Economic issues in heart failure in the United States. J Card Fail. 2022. Vol. 28(3):453-66

[15] Kristensen SL, Jhund PS, Køber L, Preiss D, Kjekshus J, McKelvie RS, et al.. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. Eur J Heart Fail. 2015. Vol. 17(2):169-76

[16] Wilcox CS, Testani JM, Pitt B. Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension. 2020. Vol. 76(4):1045-54

[17] Zheng J, Ambrosy AP, Bhatt AS, Collins SP, Flint KM, Fonarow GC, et al.. Contemporary decongestion strategies in patients hospitalized for heart failure: a national community-based cohort study. JACC Heart Fail. 2024. Vol. 12(8):1381-92

[18] Kim HJ, Jo SH. Effect of low blood pressure on prognosis of acute heart failure. Sci Rep. 2024. Vol. 14(1):15605

[19] Docherty KF, Shen L, Castagno D, Petrie MC, Abraham WT, Böhm M, et al.. Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction. Eur J Heart Fail. 2020. Vol. 22(3):528-38

[20] Bhagat AA, Greene SJ, Vaduganathan M, Fonarow GC, Butler J. Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization. JACC Heart Fail. 2019. Vol. 7(1):1-12

[21] Pagnesi M, Ghiraldin D, Vizzardi E, Chiarito M, Stolfo D, Baldetti L, et al.. Detailed assessment of the “I Need Help” criteria in patients with heart failure: insights from the HELP-HF registry. Circ Heart Fail. 2023. Vol. 16(12):e011003

[22] Chiarito M, Stolfo D, Villaschi A, Sartori S, Baldetti L, Lombardi CM, et al.. Predicting survival in patients with severe heart failure: risk score validation in the HELP-HF cohort. Eur J Heart Fail. 2025. Vol. 27(4):726-36

[23] Drozdov I, Szubert B, Murphy C, Brooksbank K, Lowe DJ. Early detection of heart failure using in-patient longitudinal electronic health records. PLoS One. 2024. Vol. 19(12):e0314145

[24] Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al.. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021. Vol. 398(10304):991-1001

[25] Coats AJS, Abraham WT, Zile MR, Lindenfeld JA, Weaver FA, Fudim M, et al.. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. Eur J Heart Fail. 2022. Vol. 24(9):1665-73

[26] Herr JJ, Ravichandran A, Sheikh FH, Lala A, Chien CV, Hsiao S, et al.. Practices of referring patients to advanced heart failure centers. J Card Fail. 2021. Vol. 27(11):1251-9

[27] Pandey A, Kitzman D, Reeves G. Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management. JACC Heart Fail. 2019. Vol. 7(12):1001-11